21 CFR 1308.11 — Schedule I (Controlled Substances Act, 21 U.S.C. 812)
ecfr.gov
Policy Tracker · Country
A bill to change the law is under consideration.
Topic hub
A bill to change the law is under consideration.
Pending bill
Pending: HB9559 — IBOGAINE Act Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act (In Committee).
ecfr.gov
Federal Schedule I lists hallucinogenic substances including LSD and psilocybin, making them illegal under federal law outside DEA-registered research; state laws vary.
Editor's context for readers — background, not quoted text.
Key sections for this law haven't been quoted yet. Open the full document to read it.
Expanding Veterans’ Access to Emerging Treatments Act
To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
Did not pass; died when the session ended
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.
Innovative Therapies Centers of Excellence Act of 2025
Innovative Therapies Centers of Excellence Act
Session: January 3, 2025 – January 3, 2027
IBOGAINE Act
Session: January 3, 2025 – January 3, 2027
Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023
END 7-OH Act
End Gas Station Heroin Act
End Gas Station Heroin Act
Safe Sips Act of 2026
Loading timeline…